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The course of the four-component reactions of (2-benzimidazolyl) 
acetonitrile, carbondisulfide, isothiocyanate, and sulfur and selenium, 
respectively, is quite different. Whereas in the case of sulfur a 
tetracyclic [1,3]thiazolo[4’,5’:4,5]pyrimido[1,6-a]benzimidazol-
2(3H)-thione is formed, a zwitterionic 7-(benzimidazolium-2-yl)-
[1,2]thiaselenolo[2,3-b][1,2,4]thiaselenazole-6-thiolate (an azaselena-
dithiapentalene) is the product in the case of selenium. The structures 
of the products have been established by X-ray crystallography, and 
reaction mechanisms for their formation are proposed. 
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Introduction 
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Nowadays it is well known that selenium is an important trace element for bacteria as 
well as for animals and human beings [1,2], and organoselenium compounds are an 
important class of biologically active products [3-5]. For example, the selenoenzyme 
glutathione peroxidase (GPx) is an antioxidant, which catalyzes the reduction of 
harmful peroxides in biological systems [6-10]. In the last 20 years, a series of 
organoselenium compounds, e.g., selenaheterocycles, have been described as GPx 
mimics (cf. ref. [11-15]). Nevertheless, the synthesis of selenaheterocycles is much 
less developed than that of sulfur analogues. One drawback is the use of toxic 
selenium reagents, which are often difficult to handle, and the low stability of some 
intermediates and products. 
 
With the aim of using conveniently accessible [16,17], relatively stable, and less toxic 
isoselenocyanates as building blocks (see also ref. [18]), we have prepared a series of 
selenium-containing four- [19,20], five- [21-26], six- [27,28], seven- [29], and eight-
membered [30] heterocycles. In some cases, the reactions were carried out 
analogously to those with isothiocyanates, and the reactivity of the two 
heterocumulenes was observed to be very similar. On the other hand, heterocyclic 
selones undergo oxidative dimerization to give diselenides much faster than the 
corresponding thiones [24,26]. 
 
Recently, Ivachtchenko et al. [31] reported on the four-component reaction of (2-
benzimidazolyl) acetonitrile (1) with sulfur, aryl isothiocyanates, and carbon 
disulfide, which had been described previously by Badawey et al. [32]. After 
methylation, tetracyclic products of type 3 were obtained [31] (Scheme 1). As the 
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authors did not disclose any spectroscopic data for 3, we wanted to verify their results 
and to extend the reaction to selenium analogues. 
 
Scheme 1 
 
 
 
Results and Discussion 
With the goal of obtaining crystalline products, which are suitable for X-ray crystal-
structure determination, we used 4-bromophenyl isothiocyanate instead of the 
unsubstituted phenyl isothiocyanate as a reagent. Furthermore, we modified some 
reaction conditions because we obtained much lower yields than described in ref. 
[31]. First, 1 was treated with sulfur and triethylamine in DMF at room temperature, 
whereby the color of the solution changed to deep red. Then, a solution of 4-
bromophenyl isothiocyanate in DMF/CH2Cl2 was added slowly, and the mixture was 
heated to 60 °C. The crude product was recrystallized from DMF/2-propanol yielding 
41.7% of 2a (m.p. 245-246 °C). A likely reaction mechanism for the formation of 2 is 
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shown in Scheme 2: addition of sulfur to the anion of 1 leads to the thiolate A, which 
reacts with the isothiocyanate to give B. Ring closure by nucleophilic attack of the N-
atom at the nitrile group gives C, which undergoes a tautomerization to yield 2a. 
 
Scheme 2 
 
 
 
Treatment of 2a with carbon disulfide in DMF under reflux led to a crystalline 
condensation product, for which we propose structure 4 (see refs. [31,32]). Following 
the procedure described in ref. [31], the product was reacted with methyl iodide in 
DMF and the final product was recrystallized from DMF/ethanol to give 3a in 50.8% 
yield with respect to 2a (Scheme 2). The molecular structure of 3a was established by 
X-ray crystallography (Figure 1), which confirmed the proposed structure of 3 [31]. 
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The heterocyclic core of the molecule of 3a, together with the fused benzene ring, is 
almost planar. The maximum deviation of the 16 atoms of the polycyclic ring from 
their mean plane is 0.102(2) Å for atom N(3). On the other hand, the 4-bromophenyl 
substituent is twisted significantly out of the heterocyclic plane, with the dihedral 
angle between the two planar systems being 56.80(8)°. 
 
 
Figure 1. ORTEP-Plot [33] of the molecular structure of 3a (arbitrary numbering of 
the atoms; 50% probability ellipsoids) 
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All attempts to repeat the reaction by using selenium instead of sulfur or 4-
bromophenyl isoselenocyanate instead of the corresponding isothiocyanate failed to 
give a product analogous to 4. From the mixture of 1 with sulfur, carbon disulfide, 
and 4-bromophenyl isoselenocyanate, only 2-(1H-1,3-benzimidazol-2-yl)-N-(4-
bromophenyl)-2-cyanoselenoacetamide (5), which is the adduct of 1 and 4-
bromophenyl isoselenocyanate, was obtained (Scheme 3). This product was isolated 
in 50.5% yield when 1 and 4-bromophenyl isoselenocyanate in DMF/CH2Cl2 were 
reacted at room temperature.  
 
Scheme 3 
 
 
 
Therefore, we modified the reaction conditions again. Finally, a one-pot reaction of 1, 
selenium and triethylamine in DMF, and subsequent addition of carbon disulfide and 
4-bromophenyl isothiocyanate led to a 1:1:1:1-adduct in 45.6% yield. 
Recrystallization of the material gave crystals suitable for X-ray crystallography, 
which proved structure 6 (Scheme 4) for the adduct (Figure 2). 
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Figure 2. ORTEP-Plot [33] of the molecular structure of 6 (arbitrary numbering of the  
atoms; 50% probability ellipsoids; solvent molecules not shown) 
 
The asymmetric unit in the crystal structure of 6 contains one molecule of each of the 
Se-heterocycle, water, and DMF. The heterocyclic product is a zwitterion with a 
terminal sulfide and a protonated benzimidazole residue. The heterocyclic core of 6 
can be represented best by a superimposition of the formulae 6A and 6B (for similar 
structures see ref. [21] and literature cited therein). The lengths of the two Se–S bonds 
differ by approximately 0.32 Å and the bond lengths within the fused, almost planar, 
core heterocyclic system indicate a significant delocalization of π-electrons (Table 1). 
The maximum deviation of the eight ring atoms of this system from their mean plane 
is 0.075(4) Å for atom C(3). The attached atoms S(2), C(8), C(18), and N(17) also 
deviate only slightly from this plane (0.202(1), -0.275(4), 0.198(5) and 0.121(4) Å, 
respectively). Furthermore, the benzimidazole ring is only slightly twisted out of the 
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plane of the heterocyclic core, with the dihedral angle between the two planar systems 
being 10.5(1)°. By contrast, the plane of the 4-bromophenyl ring deviates 
significantly from the core plane, with the dihedral angle between the ring planes 
being 43.3(2)°. 
 
Table 1.  Selected bond lengths (Å) and angles (°) for 6. 
Se-C(4) 1.891(4) N(9)-C(8) 1.355(5) 
Se-S(1) 2.265(1) N(16)-C(8) 1.347(6) 
Se-S(7) 2.584(1) N(17)-C(6) 1.349(6) 
S(1)-C(2) 1.720(5) N(17)-C(18) 1.414(6) 
S(2)-C(2) 1.714(5) C(2)-C(3) 1.406(6) 
S(7)-C(6) 1.686(5) C(3)-C(4) 1.436(6) 
N(5)-C(4) 1.306(6) C(3)-C(8) 1.455(6) 
N(5)-C(6) 1.362(6)                       
    
C(4)-Se-S(1) 88.3(1) S(2)-C(2)-S(1) 114.0(2) 
C(4)-Se-S(7) 83.0(1) C(2)-C(3)-C(4) 120.1(4) 
S(1)-Se-S(7) 170.22(5) N(5)-C(4)-C(3) 121.4(4) 
C(2)-S(1)-Se 98.3(2) N(5)-C(4)-Se 121.9(3) 
C(6)-S(7)-Se 89.1(2) N(17)-C(6)-S(7) 124.1(4) 
C(4)-N(5)-C(6) 122.1(4) N(5)-C(6)-S(7) 123.9(3) 
C(6)-N(17)-C(18) 129.2(4) C(3)-C(4)-Se 116.6(3) 
C(3)-C(2)-S(2) 129.8(3) N(17)-C(6)-N(5) 112.0(4) 
C(3)-C(2)-S(1) 116.2(3)   
 
 
In the crystal structure of 6, two intramolecular hydrogen bonds link the NH groups, 
HN(9) and HN(16), of the benzimidazole to N(5) of the 1,2,4-selenathiazole and the 
exocyclic S-atom, respectively. These interactions each have a graph set motif [34] of 
S(6) (Figure 3). These amine groups actually form bifurcated hydrogen bonds, with 
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the second interaction being with the O-atoms of the water and DMF molecules, 
respectively. The third amine group also forms an intermolecular hydrogen bond with 
the O-atom of the water molecule. Thus the water molecule is accepting two hydrogen 
bonds from the same molecule of 6. Together with the intramolecular interaction 
emanating from N(9), this creates a six-membered loop with a graph set motif of      
R2,2(6). The water molecule donates intermolecular hydrogen bonds to the O-atom of 
a DMF molecule and to the exocyclic S-atom in another molecule of 6. The exocyclic 
S-atom is an acceptor of two hydrogen bonds, as is the O-atom of the DMF molecule. 
The hydrogen-bonding interactions link two pairs of molecules of the Se-compound 
and water into a centrosymmetric dimer, which has a graph set motif of R4,4(16). 
These dimers are then linked by two sets of bridges via the O-atoms of DMF 
molecules into extended columns, which run parallel to the [100] direction. The 
repeating unit of the chain consists of one S– atom from a molecule of the Se-
compound, one DMF molecule and one water molecule and can be described by the 
graph set motif of       C2,3(6) if an intramolecular hydrogen bond is included in the 
pattern. 
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Figure 3. Crystal packing of 6·DMF·H2O showing the H-bonding interactions 
(uninvolved H-atoms omitted for clarity) 
 
Scheme 4 
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A reaction mechanism for the formation of 6 is proposed in Scheme 4. Addition of the 
anion of 1 to carbon disulfide yields D, which then reacts with selenium to give 
intermediate E. Ring closure of the latter (→ F), addition of 4-bromophenyl 
isothiocyanate (→ G), and cyclization could lead to the final product, the zwitterion 6 
via tautomerization and protonation. 
 
In conclusion, the reactions of 1, aryl isothiocyanate, and carbon disulfide with sulfur 
and selenium, respectively, showed remarkable differences. Whereas in the case of 
sulfur, the proposed structure 3 [31] and, therefore, of compound 4 [31,32] was 
established unambigously, a different product, i.e. the zwitterion 6, was formed in the 
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case of selenium. This difference is surprising, as in many reactions sulfur and 
selenium compounds behave similarly. In the last few years, we have shown that 
isoselenocyanates are very useful building blocks for the preparation of 
selenaheterocycles, in analogy to the well known reactions with isothiocyanates. But 
the present study shows that the reaction course may be quite different, leading to 
different product types and, therefore, a better knowledge of the reactivity of 
isoselenocyanates in comparison with their sulfur analogues is necessary. 
 
 
Experimental 
1. General. See ref. [21]. Melting points were determined on a Mettler-FP-5 or 
Büchi-510 apparatus and are not corrected. IR spectra in KBr (cm-1), 1H (300 MHz) 
and 13C NMR spectra (75.6 MHz) in CDCl3 (ppm); 13C-signal multiplicity from 
DEPT spectra; significant peaks of CI and ESI-MS (m/z (rel. %)).  
 
2. Starting materials. 4-Bromophenyl isothiocyanate, (2-benzimidazolyl) acetonitrile 
(1), carbon disulfide, Se-powder and S-powder were purchased by Fluka AG. 4-
Bromophenyl isoselenocyanate was prepared according to ref. [16]. 
 
3. Synthesis of 3-(4-bromophenyl)-5-(methylsulfanyl)-[1,3]thiazolo[4',5':4,5]-
pyrimido[1,6-a][1,3]benzimidazole-2(3H)-thione (3a).  
3.1. Preparation of 4-amino-5-(1H-1,3-benzimidazol-2-yl)-3-(4-bromophenyl)-1,3-
thiazole-2(3H)-thione (2a). To a solution of 1 (1.57 g, 10 mmol) and sulfur (0.32 g, 
10 mmol) in DMF (3 ml), Et3N (1.5 ml) was added under stirring. A solution of 4-
bromophenyl isothiocyanate (2.14 g, 10 mmol) in CH2Cl2/DMF was added slowly, 
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the stirred mixture was heated to 60 °C for 1 h and then poured into water. The 
precipitate was filtered and recrystallized from DMF/2-propanol. Yield: 1.68 g 
(41.7%) of 2a. M.p. 245.1-246.2 °C. 1H NMR (DMSO-d6): 12.45 (broad s, NH); 7.85, 
7.42 (AA'BB', J = 8.6 Hz, 4 arom. H); 7.48 (broad s, NH2); 7.16-7.11 (m, 4 arom. H). 
13C NMR (DMSO-d6): 184.4 (s, C=S); 162.2, 147.0, 146.5, 134.5, 123.5 (5 s, 6 C); 
133.1, 131.2, 121.5 (3 d, 8 arom. CH); 80.7 (s, C). ESI-MS: 405 (100, [M(81Br)+1]+), 
403 (92, [M(79Br)+1]+). 
3.2. Preparation of 3-(4-bromophenyl)-[1,3]thiazolo[4',5':4,5]pyrimido[1,6-
a][1,3]benzimidazole-2,5(3H,4H)-dithione (4). A mixture of 2a (2.0 g, 5 mmol), 
triethylamine (2 ml), and carbon disulfide (2 ml) was heated under reflux, while DMF 
(2 ml) was added dropwise. The resulting solution was heated under reflux for 1.5 h, 
cooled to room temperature, concentrated in vacuo, and the residue was treated with 
ethanol. The solid material was recrystallized from DMF/ethanol to give 1.5 g 
(68.2%) of 4. M.p. 241.1-242.5 °C. CI-MS (i-butane): 447 (14), 446 (22), 445 (100, 
[M(81Br)-1]+), 444 (20), 443 (87, [M(79Br)-1]+), 404 (32), 402 (29). 
3.3. Preparation of 3a. To a stirred solution of 4 (0.5 g, 1.12 mmol) in DMF (6 ml) at 
room temperature, methyl iodide (1 ml) was added. After  1 h, the  mixture was 
treated with water (80-100 ml), and the precipitate was recrystallized from 
DMF/ethanol. Yield: 0.38 g (74.5%) of 3a. M.p. 281.4-281.7 °C. IR: 1638s, 1581s, 
1531m, 1490m, 1479m, 1464s, 1446s, 1410w, 1325s, 1305m, 1253s, 1234s, 1184s, 
1156w, 1088w, 1063m, 1027w, 1013m. 1H NMR (DMF-d7): 8.48 (d, J = 8.3 Hz, 1 
arom. H); 7.95, 7.72 (AA'BB', J = 8.7 Hz, 4 arom. H + 1 H); 7.68 (t, J = 8.3 Hz, 1 
arom. H); 7.59 (t, J = 8.4 Hz, 1 arom. H); 2.63 (s, Me). 13C NMR (DMF-d7): 188.2 (s, 
C=S); 157.1, 156.7, 148.9, 146.0, 143.4, 136.1, 128.7, 123.7 (8 s, 8 arom. C); 133.2, 
131.8, 127.5, 123.4, 120.1, 116.0 (6 d, 8 arom. CH); 14.73 (q, Me). CI-MS (i-butane): 
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463 (14), 462 (25), 461 (100, [M(81Br)+1]+), 460 (42), 459 (89, M(79Br)+1]+), 458 
(21). Calcd (%) for C18H11BrN4S3 (459.41): C 47.06, H 2.41, N 12.20; found: C 
46.73, H 2.67, N 12.21. 
Recrystallization from DMF gave crystals suitable for the X-ray crystal-structure 
determination. 
 
4. Synthesis of 2-(1H,3H-1,3-benzimidazol-2-yliden)-N-(4-bromophenyl)-2-
cyanoselenoacetamide (5). To a stirred solution of 1 (0.39 g, 1.9 mmol) in absolute 
DMF, triethylamine (5 equiv.) was added. After 3 min, a solution of 4-bromophenyl 
isoselenocyanate (0.5 g, 1.9 mmol) in DMF/dichloromethane (1:1, 3 ml), was slowly 
added and the mixture stirred at room temperature for 1.5 h. The solution was 
concentrated in vacuo, methanol was added, and a yellow-orange solid was formed. 
After filtration, the product was recrystallized from DMF/methanol to give 0.4 g 
(50.6%) of 5. M.p. 244.3-246.0 °C. IR: 3421w, 3013w, 2983m, 2685m, 1621s, 1601s, 
1578m, 1522s, 1482m, 1454m, 1428s, 1380s, 1251m, 1162m, 1070m, 1021m, 1008m. 
1H-NMR (DMSO-d6): 12.8 (broad s, NH); 8.80 (broad s, NH); 8.36 (d, J = 7.8 Hz, 1 
arom. H); 7.65-7.55 (m, 3 arom. H); 7.01 (BB' of AA'BB', J = 8.6 Hz, 2 arom. H); 
7.37, 7.23 (2 t-like, J ≈ 8 Hz, 2 arom. H). 13C-NMR (DMSO-d6): 177.1 (s, C=Se); 
150.0, 147.1, 145.9, 143.4, 131.2, 117.4, 116.6 (7 s, 7 C); 132.3, 124.9, 123.0, 122.8, 
117.5, 115.6 (6 d, 8 arom. CH). CI-MS (i-butane): 423 (5), 422 (5), 421 (27), 420 (8), 
419 (36), 418 (8), 417 (19), 416 (5), 415 (6), 342 (17), 341 (92), 340 (22), 339 (94), 
338 (5), 158 (100). Calcd (%) for C16H11BrN4Se (418.15): C 45.96, H 2.65, N 13.40; 
found C 45.74, H 2.88, N 13.77. 
 
5. Synthesis of 7-(3H-1,3-benzimidazol-2-yl)-2-(4-bromoanilino)-2H-
[1,2]thiaselenolo[2,3-b][1,2,4]thiaselenazole-6-thiolate (6). To a solution of 1 (0.79 
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g, 5 mmol) and selenium (0.40 g, 5 mmol) in DMF (2 ml) was added triethylamine (1 
ml). The mixture was stirred at r.t. for 3 min, then, carbondisulfide (0.7 ml) was added 
and the mixture was stirred for an additional 3 min. A solution of 4-bromophenyl 
isothiocyanate (1.07 g, 5 mmol) in DMF/dichloromethane (1:1, ca. 5 ml) was added 
slowly, the mixture stirred at r.t. for 1.5 h and concentrated in vacuo. The residue was 
treated with ethanol and the product was recrystallized from DMF/ethanol. Yield: 1.2 
g (45.6%). M.p. 260.7-261.0 °C. IR: 3316m, 1610s, 1576m, 1557s, 1500s, 1478s, 
1394s, 1326m, 1345s, 1290s, 1244m, 1220m, 1170s, 1135m, 1068m, 1023m, 1010m. 
1H-NMR (DMF-d7): 15.11, 14.79 (2 br. s, 2 NH); 11.59 (br. s, ArNH); 8.02-7.52 (m, 
8 arom. H). 13C-NMR (DMF-d7): 182.8 (s, C=S); 147.9, 139.7, 139.5, 132.0, 130.1, 
129.8, 126.6, 118.1 (8 s, 9 C); 132.6, 125.9, 125.1, 114.5 (4 d, 8 arom. CH). CI-MS 
(NH3): 494 (22), 493 (13), 492 (28), 491 (13), 490 (14), 448 (14), 447 (27), 446 (100), 
445 (69), 444 (91), 443 (44), 366 (13), 307 (24), 306 (12), 265 (58), 200 (16). Calcd 
(%) for C17H11BrN4S3Se (526.36): C 38.79, H 2.11, N 10.64; found: C 38.39, H 2.39, 
N 10.88. 
Recrystallization from DMF gave crystals suitable for the X-ray crystal-structure 
determination. 
 
6. X-ray crystal-structure determination of 3a and 5 (see Table 2 and Figures 1 
and 2)*). All measurements were made on a Nonius KappaCCD diffractometer [35] 
using graphite-monochromated MoKα radiation (λ  0.71073 Å) and an Oxford 
Cryosystems Cryostream 700 cooler. Data reduction was performed with HKL Denzo 
                                                 
*)  CCDC-258493-258494 contain the supplementary crystallographic data for this 
paper. These data can be obtained free of charge from the Cambridge 
Crystallographic Data Centre via http://www.ccdc.cam.ac.uk/data_request/cif. 
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and Scalepack [36]. The intensities were corrected for Lorentz and polarization 
effects, and an absorption correction based on the multi-scan method [37] was 
applied.  Equivalent reflections were merged. Data collection and refinement 
parameters are given in Table 2, and views of the molecules are shown in Figs. 1 and 
2. The structures were solved by direct methods using SIR92 [38], which revealed the 
positions of all non-H-atoms. The non-H-atoms were refined anisotropically. For 5, 
the H-atoms of the amine groups and the water molecule were placed in the positions 
indicated by a difference electron density map, and their positions were allowed to 
refine together with individual isotropic displacement parameters, while restraining 
the O–H and N–H bond lengths tightly to 0.84 and 0.88 Å, respectively.  The 
remaining H-atoms for 5 and all of the H-atoms for 3a were placed in geometrically 
calculated positions and refined using a riding model where each H-atom was 
assigned a fixed isotropic displacement parameter with a value equal to 1.2Ueq of its 
parent C-atom (1.5Ueq for the Me group in 3a). Refinement of each structure was 
carried out on F2 using full-matrix least-squares procedures, which minimized the 
function Σw(Fo
2-Fc
2)2. A correction for secondary extinction was not applied. Neutral 
atom scattering factors for non-H-atoms were taken from ref. [39], and the scattering 
factors for H-atoms were taken from ref. [40]. Anomalous dispersion effects were 
included in Fc [41]; the values for ƒ’ and ƒ” were those of ref. [42]. The values of the 
mass attenuation coefficients are those of ref. [43]. All calculations were performed 
using the SHELXL97 [44] program. 
 
Table 2.  Crystallographic Data for Compounds 3a and 6 
 3a 6 
Crystallized from DMF AcOEt 
Empirical formula C18H11BrN4S3 C17H11BrN4S3Se·C3H7NO·H2O 
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Formula weight [g mol-1] 459.40 617.39 
Crystal color, habit yellow, needle yellow, prism 
Crystal dimensions [mm] 0.05 × 0.10 × 0.30 0.10 × 0.17 × 0.27 
Temperature [K] 160(1) 160(1) 
Crystal system monoclinic triclinic 
Space group P21/n  P
_
,1 
Z 4 2 
Reflections for cell determination 38361 18556 
2θ range for cell determination [°] 4 –60 4 –60 
Unit cell parameters a [Å] 4.0411(1) 7.1471(1) 
 b [Å] 19.8593(4) 12.6103(3) 
 c [Å] 21.4327(4) 13.4765(4) 
 α [°] 90 99.178(1) 
 β [°] 93.266(1) 101.772(1) 
 γ  [°] 90 96.861(1) 
 V [Å3] 1717.25(6) 1159.22(5) 
Dx [g cm-3] 1.777 1.769 
µ(MoKα) [mm-1] 2.776 3.642 
Scan type φ and ω φ and ω 
2θ (max) [°] 60 60 
Transmission factors (min; max) 0.631; 0.895 0.545; 0.698 
Total reflections measured 45540 31319 
Symmetry independent reflections 4990 6749 
Reflections with I > 2σ (I) 3794 5097 
Reflections used in refinement 4990  6749 
Parameters refined; restraints 236; 0 311; 5 
Final  R(F) [I > 2σ (I) reflections] 0.0377 0.0623 
 wR(F2)  (all data) 0.0937 0.2039 
Weights:a)  a; b 0.0468; 0.6467 0.1054; 5.3394 
Goodness of fit 1.047 1.049 
Final ∆ max /σ 0.004 0.002 
∆ρ (max; min) [e Å-3] 0.54; -0.64 1.39; -2.72 
a) w = [σ 2(Fo2) + (aP)2 + bP]-1, where P = (Fo2 + 2Fc2)/3 
 
 
 
Acknowledgement 
 18 
 
 
We thank the analytical services of our institute for spectra and analyses, and 
the Swiss National Science Foundation and F. Hoffmann-La Roche AG, Basel, for 
financial support. 
 
 
 
REFERENCES 
 
[1] K. Schwarz, C. M. Foltz, J. Am. Chem. Soc., 79, 3292 (1957). 
[2] D. L. Hatfield, 'Selenium. Its Molecular Biology and Role in Human Health', 
Kluwer Academic Publ., Boston, 2001. 
[3] G. Mugesh, W.-W. Du Mont, H. Sies, Chem. Rev., 101, 2125 (2001). 
[4] S. W. May, Exp. Opin. Invest. Drugs, 11, 1261 (2002). 
[5] E. V. Ratushnaya, Y. I. Kirova, M. A. Suchkov, B. I. Drevko, V. B. Borodulin, 
Pharm. Chem. J., 36, 652 (2002). 
[6] L. Flohé, G. Loschen, W. A. Günzler, E. Eichele, Hoppe-Seyler’s Z. Physiol. 
Chem., 353, 987 (1972). 
[7] R. F. Burk, (Ed.), 'Selenium in Biology and Human Health', Springer-Verlag, 
New York, 1994. 
[8] O. Epp, R. Ladenstein, A. Wendel, Eur. J. Biochem., 133, 51 (1983). 
[9] A. L. Tappel, Curr. Top. Cell Regul., 24, 87 (1984). 
[10] L. Flohé, Curr. Top. Cell Regul., 27, 473 (1985). 
[11] A. Müller, E. Cadenas, P. Graf, H. Sies, Biochem. Pharmacol., 33, 3235 (1984). 
 19 
[12] A. Wendel, M. Fausel, H. Safayhi, G. Tiegs, R. Otter, Biochem. Pharmacol., 33, 
3241 (1984). 
[13] M. J. Pharnham, S.  Kindt, Biochem. Pharmacol., 33, 3247 (1984). 
[14] H. J. Reich, C. P. Jasperse, J. Am. Chem. Soc., 109, 5549 (1987). 
[15] T. G. Back, B. P. Dyck, J. Am. Chem. Soc., 119, 2079 (1997). 
[16] D. H. R. Barton, S. I. Parekh, M. Tajbakhsh, E. A. Theodorakis, C.-L. Tse, 
Tetrahedron, 50, 639 (1994). 
[17] M. T. Bakhsh, Y. S. Behshtiha, M. M. Heravi, J. Chem. Soc. Pakistan, 18, 159 
(1996). 
[18] M. L. Petrov, N. I. Zmitrovich, Russ. J. Gen. Chem., 69, 245 (1999). 
[19] P. K. Atanassov, A. Linden, H. Heimgartner, Heterocycles, 62, 521 (2004). 
[20] G. L. Sommen, A. Linden, H. Heimgartner, Helv. Chim. Acta, 88, 766 (2005). 
[21] Y. Zhou, H. Heimgartner, Helv. Chim. Acta, 83, 539 (2000). 
[22] Y. Zhou, A. Linden, H. Heimgartner, Helv. Chim. Acta, 83, 1576 (2000). 
[23] P. K. Atanassov, A. Linden, H. Heimgartner, Heterocycles, 61, 569 (2003). 
[24] P. K. Atanassov, Y. Zhou, A. Linden, H. Heimgartner, Helv. Chim. Acta, 85, 
1102 (2002). 
[25] G. L. Sommen, A. Linden, H. Heimgartner, Eur. J. Org. Chem., 3128 (2005). 
[26] G. L. Sommen, A. Linden, H. Heimgartner, Tetrahedron, in press. 
[27] P. K. Atanassov, A. Linden, H. Heimgartner, Helv. Chim. Acta, 86, 3235 (2003). 
[28] P. K. Atanassov, A. Linden, H. Heimgartner, Helv. Chim. Acta, 87, 1873 (2004). 
[29] G. L. Sommen, A. Linden, H. Heimgartner, Tetrahedron Lett., 46, 6723 (2005). 
[30] P. K. Atanassov, A. Linden, H. Heimgartner, Helv. Chim. Acta, 87, 1452 (2004). 
[31] A. Ivachtchenko, S. Kovalenko, O. Parkhomenko, V. Chernykh, Heterocycl. 
Commun., 8, 329 (2002). 
 20 
[32] E.-S. A. M. Badawey, A. A. Hazzaa, S. M. Rida, T. Y. Fahmy, Arch. Pharm. 
(Weinheim), 325, 565 (1992). 
[33] C. K. Johnson, ‘ORTEP II’, Report ORNL-5138, Oak Ridge National 
Laboratory, Oak Ridge, Tennessee, 1976. 
[34] J. Bernstein, R. E. Davis, L. Shimoni, N.-L. Chang, Angew. Chem., Int. Ed. 
Engl., 34, 1555 (1995). 
[35] R. Hooft, KappaCCD Collect Software, Nonius BV, Delft, The Netherlands, 
1999. 
[36] Z. Otwinowski, W. Minor, in ‘Methods in Enzymology’, Vol. 276, 
‘Macromolecular Crystallography’, Part A, Eds. C. W. Carter, Jr. and R. M. 
Sweet, Academic Press, New York, 1997, p. 307. 
[37] R. H. Blessing, Acta Crystallogr., Sect. A, 51, 33 (1995). 
[38] A. Altomare, G. Cascarano, C. Giacovazzo, A. Guagliardi, M. C. Burla, G. 
Polidori, M. Camalli, SIR92, J. Appl. Crystallogr., 27, 435 (1994). 
[39] E. N. Maslen, A. G. Fox, M. A. O'Keefe, in ‘International Tables for 
Crystallography’, Ed. A. J. C. Wilson, Kluwer Academic Publishers, Dordrecht, 
1992, Vol. C, Table 6.1.1.1, pp. 477-486. 
[40] R. F. Stewart, E. R. Davidson, W. T. Simpson, J. Chem. Phys. 42, 3175 (1965). 
[41] J. A. Ibers, W. C. Hamilton, Acta Crystallogr. 17, 781 (1964). 
[42] D. C. Creagh, W. J. McAuley, in ‘International Tables for Crystallography’, Ed. 
A. J. C. Wilson, Kluwer Academic Publishers, Dordrecht, 1992, Vol. C,  Table 
4.2.6.8, pp. 219-222. 
[43] D. C. Creagh, J. H.  Hubbell, in ‘International Tables for Crystallography’, Ed. 
A. J. C. Wilson, Kluwer Academic Publishers, Dordrecht, 1992, Vol. C,  Table 
4.2.4.3, pp. 200-206. 
 21 
[44] G. M. Sheldrick, SHELXL97, Program for the Refinement of Crystal 
Structures, University of Göttingen, Germany, 1997. 
 22 
Table 1.  Selected bond lengths (Å) and angles (°) for 6. 
Se-C(4) 1.891(4) N(9)-C(8) 1.355(5) 
Se-S(1) 2.265(1) N(16)-C(8) 1.347(6) 
Se-S(7) 2.584(1) N(17)-C(6) 1.349(6) 
S(1)-C(2) 1.720(5) N(17)-C(18) 1.414(6) 
S(2)-C(2) 1.714(5) C(2)-C(3) 1.406(6) 
S(7)-C(6) 1.686(5) C(3)-C(4) 1.436(6) 
N(5)-C(4) 1.306(6) C(3)-C(8) 1.455(6) 
N(5)-C(6) 1.362(6)                       
    
C(4)-Se-S(1) 88.3(1) S(2)-C(2)-S(1) 114.0(2) 
C(4)-Se-S(7) 83.0(1) C(2)-C(3)-C(4) 120.1(4) 
S(1)-Se-S(7) 170.22(5) N(5)-C(4)-C(3) 121.4(4) 
C(2)-S(1)-Se 98.3(2) N(5)-C(4)-Se 121.9(3) 
C(6)-S(7)-Se 89.1(2) N(17)-C(6)-S(7) 124.1(4) 
C(4)-N(5)-C(6) 122.1(4) N(5)-C(6)-S(7) 123.9(3) 
C(6)-N(17)-C(18) 129.2(4) C(3)-C(4)-Se 116.6(3) 
C(3)-C(2)-S(2) 129.8(3) N(17)-C(6)-N(5) 112.0(4) 
C(3)-C(2)-S(1) 116.2(3)   
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Table 2.  Crystallographic Data for Compounds 3a and 6 
 3a 6 
Crystallized from DMF AcOEt 
Empirical formula C18H11BrN4S3 C17H11BrN4S3Se·C3H7NO·H2O 
Formula weight [g mol-1] 459.40 617.39 
Crystal color, habit yellow, needle yellow, prism 
Crystal dimensions [mm] 0.05 × 0.10 × 0.30 0.10 × 0.17 × 0.27 
Temperature [K] 160(1) 160(1) 
Crystal system monoclinic triclinic 
Space group P21/n  P
_
,1 
Z 4 2 
Reflections for cell determination 38361 18556 
2θ range for cell determination [°] 4 –60 4 –60 
Unit cell parameters a [Å] 4.0411(1) 7.1471(1) 
 b [Å] 19.8593(4) 12.6103(3) 
 c [Å] 21.4327(4) 13.4765(4) 
 α [°] 90 99.178(1) 
 β [°] 93.266(1) 101.772(1) 
 γ  [°] 90 96.861(1) 
 V [Å3] 1717.25(6) 1159.22(5) 
Dx [g cm-3] 1.777 1.769 
µ(MoKα) [mm-1] 2.776 3.642 
Scan type φ and ω φ and ω 
2θ (max) [°] 60 60 
Transmission factors (min; max) 0.631; 0.895 0.545; 0.698 
Total reflections measured 45540 31319 
Symmetry independent reflections 4990 6749 
Reflections with I > 2σ (I) 3794 5097 
Reflections used in refinement 4990  6749 
Parameters refined; restraints 236; 0 311; 5 
Final  R(F) [I > 2σ (I) reflections] 0.0377 0.0623 
 wR(F2)  (all data) 0.0937 0.2039 
Weights:a)  a; b 0.0468; 0.6467 0.1054; 5.3394 
Goodness of fit 1.047 1.049 
Final ∆ max /σ 0.004 0.002 
∆ρ (max; min) [e Å-3] 0.54; -0.64 1.39; -2.72 
a) w = [σ 2(Fo2) + (aP)2 + bP]-1, where P = (Fo2 + 2Fc2)/3 
 
